Outcomes cannot yet be compared over the long-term
If you're using Mounjaro (Tirzepatide) for weight loss, you may be wondering about its impact on your bladder and urinary health, especially if youve noticed changes in how often youre going to the loo or have concerns about urinary tract infections (UTIs)
Last reviewed: May 23, 2026 Last updated: May 23, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Health Canada approved Apotex's Apo-Semaglutide Injection on May 1, 2026, making it the first Canadian-made generic equivalent of Ozempic
Synedica Tirzepatide as a Research Peptide Reference Synedica Tirzepatide is best understood as a research peptide reference term
Mounjaro is currently only approved to help regulate blood sugar levels in people with type 2 diabetes (T2DM), but clinical trials have shown significant weight loss as well